{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T04:24:03Z","timestamp":1781497443096,"version":"3.54.1"},"reference-count":60,"publisher":"Elsevier BV","issue":"17","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100011009","name":"WCSS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008069","name":"UCSF","doi-asserted-by":"publisher","award":["NIH P41-GM103311"],"award-info":[{"award-number":["NIH P41-GM103311"]}],"id":[{"id":"10.13039\/100008069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.bmc.2019.07.033","type":"journal-article","created":{"date-parts":[[2019,7,19]],"date-time":"2019-07-19T11:43:37Z","timestamp":1563536617000},"page":"3918-3928","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["COX-1\/COX-2 inhibition activities and molecular docking study of newly designed and synthesized pyrrolo[3,4-c]pyrrole Mannich bases"],"prefix":"10.1016","volume":"27","author":[{"given":"Aleksandra","family":"Redzicka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0141ukasz","family":"Szczukowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Kochel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benita","family":"Wiatrak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"G\u0119bczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u017baneta","family":"Czy\u017cnikowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.bmc.2019.07.033_b0005","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1021\/jm0613166","article-title":"Structural and functional basis of cyclooxygenase inhibition","volume":"50","author":"Blobaum","year":"2007","journal-title":"J Med Chem"},{"issue":"12","key":"10.1016\/j.bmc.2019.07.033_b0010","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1096\/fasebj.12.12.1063","article-title":"Cyclooxygenase in biology and disease","volume":"12","author":"Dubois","year":"1998","journal-title":"FASEB J"},{"issue":"1","key":"10.1016\/j.bmc.2019.07.033_b0015","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1146\/annurev.pharmtox.38.1.97","article-title":"Cyclooxygenases 1 and 2","volume":"38","author":"Vane","year":"1998","journal-title":"Annu Rev Pharmacol Toxicol."},{"issue":"1","key":"10.1016\/j.bmc.2019.07.033_b0020","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/bdra.10032","article-title":"Expression of cyclooxygenase-2 in embryonic and fetal tissues during organogenesis and late pregnancy","volume":"67","author":"Stanfield","year":"2003","journal-title":"Birth Defects Res Part A Clin Mol Teratol"},{"issue":"9204","key":"10.1016\/j.bmc.2019.07.033_b0025","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S0140-6736(99)12031-2","article-title":"COX-1, COX-2, and COX-3 and the future treatment of chronic inflammatory disease","volume":"355","author":"Willoughby","year":"2000","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.bmc.2019.07.033_b0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-0038-1656307","article-title":"Extra-cranial bleeding and other symptoms due to low dose aspirin and low intensity oral anticoagulation","volume":"68","author":"Meade","year":"1992","journal-title":"Thromb Haemost."},{"key":"10.1016\/j.bmc.2019.07.033_b0035","doi-asserted-by":"crossref","unstructured":"J.G. Ruiz D.T. Lowenthal NSAIDS and nephrotoxicity in the elderly Geriatr Nephrol Urol 1997 7 1 51-57 http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9422440 accessed 8.03.19.","DOI":"10.1023\/A:1008288532636"},{"issue":"6","key":"10.1016\/j.bmc.2019.07.033_b0040","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0002-9343(99)00363-0","article-title":"Distribution and expression of cyclooxygenase (COX) isoenzymes, their physiological roles, and the categorization of nonsteroidal anti-inflammatory drugs (NSAIDs)","volume":"107","author":"Wallace","year":"1999","journal-title":"Am J Med"},{"issue":"7","key":"10.1016\/j.bmc.2019.07.033_b0045","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1021\/jm970432t","article-title":"Cytotoxic activities of Mannich bases of chalcones and related compounds","volume":"41","author":"Dimmock","year":"1998","journal-title":"J Med Chem"},{"issue":"1","key":"10.1016\/j.bmc.2019.07.033_b0050","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ejmech.2003.09.011","article-title":"Cytotoxic and anticonvulsant aryloxyaryl Mannich bases and related compounds","volume":"39","author":"Vashishtha","year":"2004","journal-title":"Eur J Med Chem"},{"issue":"7","key":"10.1016\/j.bmc.2019.07.033_b0055","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1016\/j.ejmech.2010.03.008","article-title":"Synthesis and structure-activity relationship study of 8-hydroxyquinoline-derived Mannich bases as anticancer agents","volume":"45","author":"Shaw","year":"2010","journal-title":"Eur J Med Chem"},{"issue":"11\u201312","key":"10.1016\/j.bmc.2019.07.033_b0060","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/j.ejmech.2007.02.019","article-title":"Cytotoxic Mannich bases of 6-(3-aryl-2-propenoyl)-2(3H)-benzoxazolones","volume":"42","author":"Ivanova","year":"2007","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2019.07.033_b0065","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejmech.2013.05.044","article-title":"Synthesis and biological activity evaluation of 5-pyrazoline substituted 4-thiazolidinones","volume":"66","author":"Havrylyuk","year":"2013","journal-title":"Eur J Med Chem"},{"issue":"9","key":"10.1016\/j.bmc.2019.07.033_b0070","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.1016\/j.ejmech.2011.05.054","article-title":"Design, synthesis and bioevaluation of novel candidate selective estrogen receptor modulators","volume":"46","author":"Yadav","year":"2011","journal-title":"Eur J Med Chem"},{"issue":"11","key":"10.1016\/j.bmc.2019.07.033_b0075","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.1016\/j.ejmech.2009.07.009","article-title":"Design and one-pot synthesis of \u03b1-aminophosphonates and bis(\u03b1-aminophosphonates) by iron(III) chloride and cytotoxic activity","volume":"44","author":"Rezaei","year":"2009","journal-title":"Eur J Med Chem"},{"issue":"9","key":"10.1016\/j.bmc.2019.07.033_b0080","doi-asserted-by":"crossref","first-page":"4258","DOI":"10.1016\/j.ejmech.2011.06.031","article-title":"Synthesis and biological evaluation of novel Mannich bases of 2-arylimidazo[2,1-b]benzothiazoles as potential anti-cancer agents","volume":"46","author":"Kumbhare","year":"2011","journal-title":"Eur J Med Chem"},{"issue":"13","key":"10.1016\/j.bmc.2019.07.033_b0085","doi-asserted-by":"crossref","first-page":"5733","DOI":"10.1021\/acs.jmedchem.8b00777","article-title":"Indolyl azaspiroketal Mannich bases are potent antimycobacterial agents with selective membrane permeabilizing effects and in vivo activity","volume":"61","author":"Nyantakyi","year":"2018","journal-title":"J Med Chem"},{"issue":"1","key":"10.1016\/j.bmc.2019.07.033_b0090","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.bmcl.2004.09.084","article-title":"Synthesis and in vitro study of novel Mannich bases as antibacterial agents","volume":"15","author":"Joshi","year":"2005","journal-title":"Bioorg Med Chem Lett"},{"issue":"10","key":"10.1016\/j.bmc.2019.07.033_b0095","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0223-5234(02)01404-6","article-title":"Synthesis and antibacterial activity of fused Mannich ketones","volume":"37","author":"L\u00f3r\u00e1nd","year":"2002","journal-title":"Eur J Med Chem"},{"issue":"11","key":"10.1016\/j.bmc.2019.07.033_b0100","doi-asserted-by":"crossref","first-page":"5225","DOI":"10.1016\/j.ejmech.2010.08.039","article-title":"Synthesis and biological evaluation of some 1,3,4-oxadiazole derivatives","volume":"45","author":"Manjunatha","year":"2010","journal-title":"Eur J Med Chem"},{"issue":"11","key":"10.1016\/j.bmc.2019.07.033_b0105","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.ejmech.2004.07.007","article-title":"Novel Mannich ketones of oxazolidinones as antibacterial agents","volume":"39","author":"Srivastava","year":"2004","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2019.07.033_b0110","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ejmech.2013.07.024","article-title":"Synthesis and antimicrobial activity of novel 5-(1-adamantyl)-2-aminomethyl-4-substituted-1,2,4-triazoline-3-thiones","volume":"68","author":"El-Emam","year":"2013","journal-title":"Eur J Med Chem"},{"issue":"3","key":"10.1016\/j.bmc.2019.07.033_b0115","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.ejmech.2008.06.019","article-title":"Synthesis of some new 1,2,4-triazoles, their Mannich and Schiff bases and evaluation of their antimicrobial activities","volume":"44","author":"Bayrak","year":"2009","journal-title":"Eur J Med Chem"},{"issue":"11","key":"10.1016\/j.bmc.2019.07.033_b0120","doi-asserted-by":"crossref","first-page":"5120","DOI":"10.1016\/j.ejmech.2010.08.023","article-title":"Synthesis and pharmacological evaluation of clubbed isopropylthiazole derived triazolothiadiazoles, triazolothiadiazines and mannich bases as potential antimicrobial and antitubercular agents","volume":"45","author":"Suresh Kumar","year":"2010","journal-title":"Eur J Med Chem"},{"issue":"9","key":"10.1016\/j.bmc.2019.07.033_b0125","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0223-5234(01)01264-8","article-title":"Synthesis and antibacterial study of unsaturated Mannich ketones","volume":"36","author":"L\u00f3r\u00e1nd","year":"2001","journal-title":"Eur J Med Chem"},{"issue":"1","key":"10.1016\/j.bmc.2019.07.033_b0130","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3998\/ark.5550190.0007.113","article-title":"Synthesis and primary antiviral activity evaluation of 3-hydrazono-5-nitro-2-indolinone derivatives","volume":"2006","author":"Terzioglu","year":"2005","journal-title":"Arkivoc"},{"issue":"13","key":"10.1016\/j.bmc.2019.07.033_b0135","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1016\/j.bmc.2009.05.001","article-title":"Synthesis and in vitro anti-hepatitis B virus activity of 6H-[1]benzothiopyrano[4,3-b]quinolin-9-ols","volume":"17","author":"Jia","year":"2009","journal-title":"Bioorg Med Chem"},{"issue":"4","key":"10.1016\/j.bmc.2019.07.033_b0140","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.bmc.2005.08.041","article-title":"Synthesis and in vitro anti-hepatitis B virus activities of some ethyl 6-bromo-5-hydroxy-1H-indole-3-carboxylates","volume":"14","author":"Chai","year":"2006","journal-title":"Bioorg Med Chem"},{"issue":"2","key":"10.1016\/j.bmc.2019.07.033_b0145","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.bmcl.2009.11.068","article-title":"Synthesis and biological evaluation of nitrogen-containing chalcones as possible anti-inflammatory and antioxidant agents","volume":"20","author":"Bandgar","year":"2010","journal-title":"Bioorg Med Chem Lett"},{"issue":"3","key":"10.1016\/j.bmc.2019.07.033_b0150","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s00044-009-9194-8","article-title":"Design and synthesis of 3-[3-(substituted phenyl)-4-piperidin-1-ylmethyl\/-4-morpholin-4-ylmethyl-4,5-dihydro-isoxazol-5-yl]-1H-indoles as potent anti-inflammatory agents","volume":"19","author":"Amir","year":"2010","journal-title":"Med Chem Res"},{"issue":"7","key":"10.1016\/j.bmc.2019.07.033_b0155","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1016\/j.ejmech.2010.04.005","article-title":"Synthesis, anti-inflammatory and ulcerogenicity studies of some substituted pyrimido[1,6-a]azepine derivatives","volume":"45","author":"El-Sayed","year":"2010","journal-title":"Eur J Med Chem"},{"issue":"9","key":"10.1016\/j.bmc.2019.07.033_b0160","doi-asserted-by":"crossref","first-page":"4100","DOI":"10.1016\/j.ejmech.2011.06.010","article-title":"Synthesis, characterization and pharmacological activity of 4-{[1-substituted aminomethyl-4-arylideneamino-5-sulfanyl-4,5-dihydro-1H-1,2,4-triazol-3-yl]methyl}-2H-1,4-benzothiazin-3(4H)-ones","volume":"46","author":"Gowda","year":"2011","journal-title":"Eur J Med Chem"},{"issue":"6","key":"10.1016\/j.bmc.2019.07.033_b0165","first-page":"586","article-title":"Synthesis and anti-inflammatory activity of Chalcones and related Mannich bases","volume":"4","author":"Kouskoura","year":"2008","journal-title":"Med Chem (Los Angeles)"},{"issue":"5","key":"10.1016\/j.bmc.2019.07.033_b0170","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1016\/j.ejmech.2008.03.043","article-title":"Synthesis, pharmacological screening, quantum chemical and in vitro permeability studies of N-Mannich bases of benzimidazoles through bovine cornea","volume":"44","author":"Jesudason","year":"2009","journal-title":"Eur J Med Chem"},{"issue":"9","key":"10.1016\/j.bmc.2019.07.033_b0175","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.1016\/j.ejmech.2009.03.044","article-title":"Regioselective reaction: Synthesis and pharmacological study of Mannich bases containing ibuprofen moiety","volume":"44","author":"Sujith","year":"2009","journal-title":"Eur J Med Chem"},{"issue":"8","key":"10.1016\/j.bmc.2019.07.033_b0180","doi-asserted-by":"crossref","first-page":"3802","DOI":"10.1007\/s00044-012-0382-6","article-title":"Docking, synthesis, and pharmacological investigation of novel substituted thiazole derivatives as non-carboxylic, anti-inflammatory, and analgesic agents","volume":"22","author":"Thore","year":"2013","journal-title":"Med Chem Res"},{"key":"10.1016\/j.bmc.2019.07.033_b0185","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.ejmech.2012.06.011","article-title":"Regioselective reaction: synthesis, characterization and pharmacological activity of some new Mannich and Schiff bases containing sydnone","volume":"54","author":"Nithinchandra","year":"2012","journal-title":"Eur J Med Chem"},{"issue":"5","key":"10.1016\/j.bmc.2019.07.033_b0190","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.bmcl.2018.01.043","article-title":"Design, synthesis, anti-inflammatory activity and molecular docking of potential novel antipyrine and pyrazolone analogs as cyclooxygenase enzyme (COX) inhibitors","volume":"28","author":"El Sayed","year":"2018","journal-title":"Bioorg Med Chem Lett"},{"issue":"1","key":"10.1016\/j.bmc.2019.07.033_b0195","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.farmac.2004.10.002","article-title":"Synthesis and analgesic action of N-(substituted-ethyl)pyrrole-3,4-dicarboximides","volume":"60","author":"Malinka","year":"2005","journal-title":"Farm"},{"key":"10.1016\/j.bmc.2019.07.033_b0200","first-page":"95","article-title":"Rearrangement of some N-substituted pyrrolo(3,4-c)pyrroles to corresponding pyrrolo(3,4-c)pyridines","volume":"69","author":"Malinka","year":"1995","journal-title":"Polish J Chem"},{"issue":"5","key":"10.1016\/j.bmc.2019.07.033_b0205","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1053\/bega.2001.0236","article-title":"COX-1 and COX-2 inhibitors","volume":"15","author":"Hawkey","year":"2001","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"26","key":"10.1016\/j.bmc.2019.07.033_b0210","doi-asserted-by":"crossref","first-page":"15810","DOI":"10.1074\/jbc.271.26.15810","article-title":"A single amino acid difference between cyclooxygenase-1 (COX-1) and -2 (COX-2) reverses the selectivity of COX-2 specific inhibitors","volume":"271","author":"Gierse","year":"1996","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.bmc.2019.07.033_b0215","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/j.bmcl.2008.07.048","article-title":"Microwave-assisted synthesis of N-substituted cyclic imides and their evaluation for anticancer and anti-inflammatory activities","volume":"19","author":"Sondhi","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"issue":"9","key":"10.1016\/j.bmc.2019.07.033_b0220","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1016\/S0968-0896(02)00152-9","article-title":"Synthesis and anti-inflammatory activity of phthalimide derivatives, designed as new thalidomide analogues","volume":"10","author":"Lima","year":"2002","journal-title":"Bioorg Med Chem"},{"issue":"2","key":"10.1016\/j.bmc.2019.07.033_b0225","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jsb.2011.07.019","article-title":"The structure of NS-398 bound to cyclooxygenase-2","volume":"176","author":"Vecchio","year":"2011","journal-title":"J Struct Biol"},{"issue":"1","key":"10.1016\/j.bmc.2019.07.033_b0230","first-page":"9","article-title":"Synthesis of some N-substituted 3,4-pyrroledicarboximides as potential CNS depressive agents","volume":"55","author":"Malinka","year":"2000","journal-title":"Pharmazie"},{"key":"10.1016\/j.bmc.2019.07.033_b0235","unstructured":"CrysAlis RED, CrysAlis CCD, Oxford Diffraction Ltd., Version 1.171.33.66."},{"issue":"1","key":"10.1016\/j.bmc.2019.07.033_b0240","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1107\/S2053229614024218","article-title":"Crystal structure refinement with SHELXL","volume":"71","author":"Sheldrick","year":"2015","journal-title":"Acta Crystallogr Sect C Struct Chem"},{"issue":"5","key":"10.1016\/j.bmc.2019.07.033_b0245","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1107\/S0021889899011486","article-title":"DIAMOND \u2013 visual crystal structure information System","volume":"32","author":"Pennington","year":"1999","journal-title":"J Appl Crystallogr"},{"issue":"7","key":"10.1016\/j.bmc.2019.07.033_b0250","doi-asserted-by":"crossref","first-page":"5648","DOI":"10.1063\/1.464913","article-title":"Density-functional thermochemistry. III. The role of exact exchange","volume":"98","author":"Becke","year":"1993","journal-title":"J Chem Phys"},{"key":"10.1016\/j.bmc.2019.07.033_b0255","series-title":"Density-functional theory of atoms and molecules","author":"Parr","year":"1989"},{"issue":"2","key":"10.1016\/j.bmc.2019.07.033_b0260","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1103\/PhysRevB.37.785","article-title":"Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density","volume":"37","author":"Lee","year":"1988","journal-title":"Phys Rev B"},{"issue":"8","key":"10.1016\/j.bmc.2019.07.033_b0265","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.1063\/1.474659","article-title":"A new integral equation formalism for the polarizable continuum model: theoretical background and applications to isotropic and anisotropic dielectrics","volume":"107","author":"Canc\u00e8s","year":"1997","journal-title":"J Chem Phys"},{"issue":"8","key":"10.1016\/j.bmc.2019.07.033_b0270","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1021\/cr9904009","article-title":"Quantum mechanical continuum solvation models","volume":"105","author":"Tomasi","year":"2005","journal-title":"Chem Rev"},{"issue":"1\u20133","key":"10.1016\/j.bmc.2019.07.033_b0275","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0166-1280(98)00553-3","article-title":"The IEF version of the PCM solvation method: an overview of a new method addressed to study molecular solutes at the QM ab initio level","volume":"464","author":"Tomasi","year":"1999","journal-title":"J Mol Struct Theochem"},{"key":"10.1016\/j.bmc.2019.07.033_b0280","unstructured":"M.J. Frisch, G.W. Trucks, H.B. Schlegel, et al. Gaussian 09 Revision C.01. 2009."},{"issue":"1","key":"10.1016\/j.bmc.2019.07.033_b0285","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The Protein Data Bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res"},{"issue":"16","key":"10.1016\/j.bmc.2019.07.033_b0290","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J Comput Chem."},{"issue":"13","key":"10.1016\/j.bmc.2019.07.033_b0295","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera?A visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J Comput Chem"},{"issue":"2","key":"10.1016\/j.bmc.2019.07.033_b0300","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/protein\/8.2.127","article-title":"LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions","volume":"8","author":"Wallace","year":"1995","journal-title":"Protein Eng."}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089619306820?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089619306820?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:04:26Z","timestamp":1760835866000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089619306820"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":60,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S0968089619306820"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2019.07.033","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COX-1\/COX-2 inhibition activities and molecular docking study of newly designed and synthesized pyrrolo[3,4-c]pyrrole Mannich bases","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2019.07.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}